2020 Council Election: Meet the Candidates

The online election is being managed by Simply Voting. IGCS Members with voting rights will receive a link to the online ballot from the email address, vote@simplyvoting.com starting on Sunday, April 5th and will receive weekly reminders to vote through May 5, 2020.

A link to the online ballot will also be posted here when the election opens on April 5th. Until then, please get to know the candidates and read their personal statements below.

President Elect

For the year 2020, the position of President Elect must be filled by a member residing in Asia or Oceania.
Prof. Keiichi Fujiwara was elected by nomination. Congratulations, Keiichi!

Keiichi Fujiwara, MD, PhD
Professor and Director, Dept. of Gynecologic Oncology
Saitama Medical University Int’l Medical Center

Specialty: Gynecologic Oncology

Read Keiichi's Election Profile

IGCS Activities:

  • IGCS Biennial Meeting Scientific Program Committee Co-Chair (Kyoto 2018)
  • IGCS Secretary-Treasurer (2012-2014)
  • IGCS Secretary-Treasurer Elect (2010-2012)
  • Senior Editor of the International Journal of Gynecological Cancer (2008-2013)
  • IGCS Finance Committee Member (2005-2007)

Personal Statement:

It is my great honor to have the opportunity to be a candidate for President-Elect position of IGCS.

I have been a member of IGCS since 1995, was a member of the Finance Committee from 2005 to 2007 and Secretary Treasurer of the Society from 2012 to 2014.  I have also served as a Senior Editor of the International Journal of Gynecologic Cancer from 2008 to 2013. The biggest opportunity for me so far to contribute to the Society was at the IGCS Annual Meeting held in Kyoto, Japan, 2018 as Scientific Co-Chair. During my career and with that experience, I have witnessed the impressive growth of IGCS and have also learned that IGCS is the number one society to connect the gynecologic cancer communities on a global scale.

My career as a gynecologic oncologist started by learning the importance of evidence-based medicine and then it advanced to learning evidence generating processes, especially in the planning and conducting of clinical trials. This process is important not only to establish the evidence for future patient care but also to improve the quality of daily practice. Building clinical trial infrastructure requires multidisciplinary collaboration with nurses and other co-medical staff to support and protect our patients. I strongly believe this experience has given me the opportunity to lead multidisciplinary committees such as those within the IGCS whose membership is diverse.

To achieve this purpose, I would like to propose that the IGCS enhances further collaboration with nursing and other healthcare professionals and more importantly with our patients, both of which the Society has recently started.

After almost two decades of learning about and being actively involved in clinical trials, I have recently had the opportunity to serve as Chair of the Gynecologic Cancer Intergroup, GCIG, which is the global network of clinical trial groups worldwide (October 2018 until October 2020). 

In the past, evidence generation has been performed mainly in developed countries where resources and the infrastructure support of clinical trials are well established. It is now necessary to ensure that clinical trial expertise is disseminated to other part of the globe to fit the evidences in those areas by considering the uniqueness and differences in ethnical and cultural backgrounds. 

The training of clinical trial specialists is the role of the clinical trial group. In contrast, the role of the IGCS is to spread the importance of clinical trials, encourage researchers who want to go down that path, and appeal to hospital managers and government officials about the importance of building infrastructure to support clinical trials. A strong partnership between IGCS and GCIG and particularly CCRN will ensure that women in low- and middle-income countries will receive all the benefits that an active clinical trial program produces.

During my experience working with a number of world-class leaders in the gynecologic oncology community, I have learned the importance of synergies generated by working together in a collegial and respectful fashion. As President of IGCS I would hope the international community of caregivers in women’s health will grow more closely together and that our patients will have improved outcomes as a result. It is my great honor to be considered for this position.

Candidates for Vice President

Michael Birrer, MD, PhD
Director, Winthrop P. Rockefeller Cancer Institute
University of Arkansas for Medical Sciences
United States

Specialty: Medical Oncology & Translational Research

Read Michael's Election Profile

IGCS Activities:

  • Consistent reviewer for the International Journal of Gynecological Cancer
  • IGCS Biennial Meeting Scientific Program Committee Member (Bangkok 2008)
  • Invited Speaker, IGCS Annual Global Meeting (Rio de Janiero 2019)

Personal Statement:

I have dedicated my professional life to the diagnosis and treatment of women with gynecologic cancers. Caring for woman suffering from these diseases has been a great satisfaction for me.  In addition, this effort has included running a fully funded genomics laboratory along with a consistent focus on translating these results into the design and activation of “cutting edge” clinical trials.  Many of these projects involve large consortiums of national and international collaborators unified by a mutual interest in understanding the molecular underpinnings of gynecologic cancers and ultimately helping women with these diseases.

My administrative experience includes a broad and deep experience in participating in and leading many national and international committees and organizations focused on gynecologic cancers. This includes the Gynecologic Cancer Intergroup Committee, Society of Gynecologic Oncology, Cancer Research UK, Department of Defense Ovarian Cancer Research Program, and American Society of Clinical Oncology to name a few. These experiences mean that I have worked with many of the investigators in the field and they are familiar with my abilities and style. My leadership style is best described as inclusive, collaborative and supportive. It is critical that the best and innovative researchers are always given a chance to participate and that we encourage and support our young investigators. 

It would be a great honor for me to serve on one of the premier professional organization focused upon gynecologic cancer patients. I would hope to help spread IGCS’s message and expand its mission particularly to underserved populations throughout the world. My background as both a medical oncologist and translational researcher would help bring a different viewpoint and novel approach to the leadership of the group. A strong effort to engage and encourage laboratory based researchers would be very important for IGCS. In many ways, the future of the field is dependent upon translation laboratory research into novel drug discoveries. These are two areas that I have extensive experience in and I would be delighted to promote within the organization.

Jae-Weon Kim, MD, PhD
Professor and Director, Gynecologic Oncology Center
Seoul National University
Republic of Korea

Specialty: Gynecologic Oncology

Read Jae-Weon's Election Profile

IGCS Activities:

  • Member of the Scientific Program Committee at 16th and 18th IGCS Meetings (Lisbon 2016; Rome 2020)
  • Senior Editor, International Journal of Gynecological Cancer (2008-2018)
  • Attended and presented at 6th, 10th, 11th, 13th, 14th, 15th, 16th, and 17th IGCS Biennial Meetings

Personal Statement:

As a devoted member of the IGCS for the last 23 years, I would be honored to be elected as Vice President to assist in the further development of the organization. Since the 6th IGCS meeting held in Fukuoka in 1997, I have served as not only a member of the scientific program committee but also as a Senior Editor for the IJGC from 2008 to 2018. I have been proactively involved with the Gynecologic Cancer InterGroup (GCIG) as a representative of the Korean group since 2004. In addition, I have been served for more than 10 years to the Asian SGO as a Council member, Treasurer, and Editor-in-Chief of the ‘Journal of Gynecologic Oncology’ and am currently active as President-Elect.

During my career, I have come to realize that there are plenty of unrevealed and unmet needs in the gynecologic field, especially in underdeveloped countries. Considering the variety of needs and available resources in different areas, as well as the diversity of each social and clinical environment, we need to develop more refined localized approaches to help out our colleagues and women suffering from gynecologic cancers. With international collaboration and communication with mutual respect between members of the IGCS, we can make a significant change and I would like to serve as a bridge between IGCS and several regional societies to make this possible.

I would also like to contribute in the enhancement and optimization of international collaboration for clinical studies among members of the IGCS. To achieve scientific excellence, frontier researches should be promoted and the exchange of knowledge between multidisciplinary researchers worldwide should be facilitated in an efficient and enjoyable way. This should especially be possible in young gynecologic oncologists, especially those studying in developing areas. I would like to create more innovative approaches for these young researchers by expanding overseas training opportunities and scholarships, which are supported by the IGCS and other donors.

If I were elected as Vice President of the IGCS, I would do my best to support the activities of the President and Council members and would definitely spend my time and energy to serve the Members and Society, and keep achieving the IGCS mission worldwide.

R. Wendel Naumann, MD
Professor and Director of Research in Gynecologic Oncology, Associate Medical Director of Clinical Trials
Levine Cancer Institute, Atrium Health, Charlotte, NC
United States

Specialty: Gynecologic Oncology

Read Wendel's Election Profile

IGCS Activities:

  • IGCS Annual Global Meeting Scientific Program Committee Member (Rome 2020)
  • Organizer and Moderator of the IGCS LiveStream Gynecologic Cancer Update (2019)
  • Project ECHO® Virtual Tumor Board Contributor (2018-Present)
  • IGCS Biennial Meeting Scientific Program Committee Member (Vancouver 2012)

Personal Statement:

The IGCS is now the primary organization for education in gynecologic oncology worldwide.  I have a long commitment to educational leadership in the care of women with gynecologic malignancies and want to continue my service within the IGCS. 

I have served on the clinical practice committee for the SGO and later the education committee, ultimately becoming the chair of the education committee. I have served on the executive board for the SGO as well as the program committee for SGO and IGCS five times. In addition, I have organized multiple meetings including serving as the co-director of the SGO winter meeting for the past five years.   Last year I organized a LiveStream meeting for the IGCS that was broadcast to over 300 people in 88 countries. The LiveStream effort is ongoing, and we are excited about our current project which will be a joint surgical symposium and film festival in conjunction with AAGL for this spring.  I have also been involved with international outreach as part of a joint NCI/IGCS education mission to improve screening for cervical cancer in Belarus and Kazakhstan and have hosted two international fellows at our institution.

My involvement has made me realize that that efforts in education within the IGCS can have a major impact on the care of women with gynecologic malignancies throughout the world and this continues to fuel my passion for these educational efforts.  As the IGCS continues to grow and expand, we will have a greater opportunity to reach more members to positively impact the care of women with gynecologic malignancies. I am committed to finding new ways to educate and allow our members to interact and learn from each other. My hope is that we can expand education on palliative care as major effort to relieve suffering, improve access to genetic testing, as well as continue to update our membership on the latest developments in cancer, even if our members cannot attend the annual meeting.  To do this we will need to find better ways to communicate and educate our constituents. 

In addition, I would like to develop case-based learning curriculum for both common and rare gynecologic malignancies and continue to expand opportunities for surgical training and mentorship.  It is clear to me that IGCS is in the position to have a major impact on global care of women with gynecologic malignancies and complex gynecologic surgical problems and I very much want to be a part of the leadership of this organization.

Candidates for Secretary-Treasurer Elect

Vivek Arora, MD
Consultant Gynaecological Oncologist
Prince of Wales Private Hospital, Sydney

Specialty: Gynecologic Oncology

Read Vivek's Election Profile

IGCS Activities:

  • IGCS Council Member Representing Asia/Oceania (2016-2020)
  • International Mentor, IGCS Gynecologic Oncology Global Curriculum & Mentorship Program for Hamad Medical Corporation Women’s Hospital, Qatar (2019-Present)
  • IGCS Global Network (Online Member Community) Moderator (2018-2019)
  • IGCS Mentorship & Training Committee Member (2018-Present)
  • IGCS Visiting Scholar & Mentorship Program Chair (2018-Present)
  • Project ECHO® Virtual Tumor Board Contributor (2018-Present)
  • Organizer of IGCS & ASGO Visiting Scholars Program for the 2014 IGCS Biennial Meeting in Melbourne
  • Panelist, “Training and Career Development in Gynecologic Oncology” at the inaugural Shingo Fujii Young Doctors Summit at the 2012 IGCS Biennial Meeting in Vancouver

Personal Statement:

As a gynaecological oncologist who has trained and worked across 3 continents, I have been privileged to witness how the specialty has grown over the last 2 decades. I have also witnessed, from close quarters, the disparity that still exists in different parts of the world. Advances in treatment options for gynaecological cancer benefit a lot of women, but also further highlight these disparities.

As a Council Member of the IGCS over the last 4 years, my focus has been to further the goals of IGCS in international collaboration, mentorship and support to the centers with limited resources or those with newly established gynaecological oncology programs. As a member of the IGCS Mentorship and Training Committee I have been involved with the Project ECHO outreach multi-disciplinary team meetings in gynaecological oncology and chairing the Visiting Scholar and Mentorship Program.

I feel that there is more that I can contribute to the Society and our common goals. During my term as a Council Member I have been fortunate to be a part of the tremendous growth in the Society, in membership numbers and its global presence. I seek your support for the position of Secretary-Treasurer Elect because I believe that I will be in a position to complement the efforts of the incoming IGCS Council. I have the organizational skills and the attention to detail that is required for this important role in the Society.

Hennie Botha, MBChB, MMed, FCOG, PhD
Associate Professor
Stellenbosch University and Tygerberg Hospital
South Africa

Specialty: Gynecologic Oncology

Read Hennie's Election Profile

IGCS Activities:

  • IGCS Council Member Representing Africa/Europe/Middle East (2014-2018)
  • IGCS Regional Meeting Organizing Committee Chair (Cape Town 2014)
  • IGCS Global Curriculum & Mentorship Program Exam Committee Member (2018-Present)
  • IGCS Scientific Publications Committee (2018-Present)

Personal Statement:

The IGCS strives to unite the global community in eliminating the suffering caused by gynaecological cancers. I firmly believe international collaboration leads to the exchange and improvement of knowledge and skills, creates space for collegial support, and generates energy for progress.

I have worked in low-, middle-, and high-income countries and appreciate the challenges and opportunities of each environment. I believe people, with their attitudes and skills, are more important to success than highly advanced facilities or medicines. The IGCS is an ideal vehicle to promote linkage and solidarity amongst all of us working with people affected by cancer.

I have been a member of the IGCS for almost 20 years. My experience on the council from 2014 to 2018 and committees of the Society helps me to understand the complexity and excitement of international communication and collaboration.

The dynamic focus on education and internationalisation over the last few years created a rapid expansion of programs which calls for steady financial management. The leadership of the IGCS must ensure careful stewardship of the resources available without limiting the development agenda. There needs to be a balance between financial prudence and spending responsibly for future growth and development.

I am committed to the healthy future of the IGCS and all its members.

Rainer Kimmig, MD
Full Professor
West German Cancer Center, University of Duisburg-Essen

Specialty: Gynecologic Oncology

Read Rainer's Election Profile

IGCS Activities:

  • IGCS Council Member Representing Africa/Europe/Middle East (2016-2020)
  • IGCS Annual Global Meeting Scientific Program Committee Chair (Rome 2020)
  • IGCS Global Network (Online Member Community) Moderator (2018-Present)

Personal Statement:

Dear IGCS members and friends all around the world,

I would like to serve as your Secretary-Treasurer Elect in IGCS and ask you for your support.

As Council Member for the past 4 years I have had the opportunity to get insights into our Society, its achievements and also its potential for the coming years. I also had the chance to actively support the development of our online communication platform and our new membership directory. 

As you know, I am convinced that each of us should have the very best education and technology available. Thus, the main goal of IGCS projects must be to share knowledge and skills all around the world and bring those on the best possible level  for everyone. This must be accompanied by evaluating the chances to implement modern technology according to each country’s resources and to develop specific skills to compensate for lack of technology wherever possible.

Thus, for the Secretary-Treasurer it is crucial not only to ensure a healthy economical/financial situation of the society, but also to support the projects most suitable to achieve these goals. This will bring the Society into a bright future being the world’s leading voice in gynecologic oncology with a powerful impact on womens’ health.  I would be very happy if I could further contribute to this promising future of the Society with all my experience and my heart beating for IGCS.

Before being elected for the IGCS Council, I worked 6 years in the ESGO Council as “Educational Chair” and Vice President. Currently, I am serving as President of SERGS (Society of European Robotic Gynaecological Surgery) after 6 years experience as Council Member and Secretary/Treasurer.

Dear friends, please give me your trust and confidence; I will work hard for you and our Society.

Health, Luck and Happiness to all of you.

Yours, Rainer

Candidates for Council Member (Americas)

Carolyn Johnston, MD
Clinical Professor Emeritus
University of Michigan
United States

Specialty: Gynecologic Oncology

Read Carolyn's Election Profile

IGCS Activities:

  • International Mentor, IGCS Gynecologic Oncology Global Curriculum & Mentorship Program for St. Paul Millennium Medical College and Black Lion Hospital in Addis Ababa, Ethiopia (2017-Present)
  • Project ECHO® Virtual Tumor Board Contributor  (2018-Present)

Personal Statement:

I feel that it is my turn to be of service to an organization that has given so much support to the fellows whom I mentor and admire. These fellows have either benefitted from membership in an IGCS sponsored fellowship and its attendant assets (Ethiopia) or from IGCS-sponsored travel and visiting scholar grants (Ghana). Thus, so too have I gained from the IGCS. I also believe, that although it is great to have a diverse and large membership, that individual members need to work together to build a sustainable product, particularly in locations where quickly the mentee becomes the mentor for the next batch of trainees. How to continue to provide that support while moving on to new locations is a challenge, but one worthy of attention.

I, like others, have spent decades in one location (Kumasi, Ghana) helping to build a sustainable future for gynecologic oncology training. This continuity has allowed me to understand many of the political, economic, social and personal challenges of being a gynecologic oncology fellow in the developing world, where one cannot simply stop every day medical work and dedicate all their time to specialty training, but must also continue to support the department as a generalist and teacher of medical students and residents, as well as work in a private practice setting to support themselves. Training and teaching in this environment have taught me patience and humility, enriched my teaching skills and given me great friends and colleagues. In addition, I have taught and trained many fellows in a gynecologic oncology fellowship program at an academic institution in the USA for 30 years which requires a different and more complex, and perhaps more rigid, approach to training. This apparent dichotomy gives me a unique understanding of international needs and possibilities. I was also fortunate to be a contributing member of the Sister Society which helped to develop the curriculum that is now used in the IGCS sponsored fellowships.

Given that I am primarily retired, working only one week a month while also continuing to travel to Ethiopia and Ghana for fellowship-related teaching, I have more time to devote to the IGCS council, should I be selected. I have significant past leadership and not-for-profit advisory board member experience (Michigan Cancer Consortium, ACS Great Lakes Division Board of Directors, ECHO tumor board) and work well in groups as a team member. I am however not reluctant to take the lead if a situation requires it, and I appreciate being continually challenged.  This all said, it would be a privilege to be elected to the council.

Mario Mendes Leitao, Jr., MD
Attending Surgeon
Memorial Sloan-Kettering Cancer Center
United States

Specialty: Gynecologic Oncology

Read Mario's Election Profile

IGCS Activities:

  • IGCS Annual Global Meeting Scientific Program Committee Member (Rio de Janeiro 2019; Rome 2020)
  • IGCS Biennial Meeting Scientific Program Committee Member (Lisbon 2016)

Personal Statement:

My passion is to cure women with gynecologic malignancies. As an individual physician and surgeon, one can only directly impact a small number of women. The only way to truly make a difference in the care of women with gynecologic cancers around the world is through strong and fruitful relationships among the many colleagues who care for these women. I have dedicated my life to not only helping the women that I see but also to sharing whatever knowledge I may have with as many colleagues as will be interested to hear. This can only be done through international dialogue and discussions. I have been fortunate to have been invited all over the world to share my thoughts and knowledge with others.

However, it is I that have learned so much more from the privilege I have been given to learn from the experience of so many talented physicians and non-physicians from every part of the world. As Chair of the Membership Committee for the SGO, it was my primary goal to expand the membership to as many International colleagues as would want to join. The SGO Members voted to adopt the historic membership criteria changes that we developed in the membership committee which made it possible for International colleagues to join easily.

I have sponsored numerous colleagues from around the world to come and observe at our institution, including UICC fellows. I am fellowship director of the only established, continuous, and fully structured International Fellowship in Gynecologic Oncology in the United States. I can take my prior experience, passion for international collaboration and the friendships I have made of so many colleagues around the world to enhance the work of the IGCS which has already made tremendous progress in the advancement of care of women around the world. I also value International collaboration from a personal standpoint. My parents are both immigrants from Portugal and the majority of my family is in Portugal and Brazil. I have been honored with a Membership in the Surgical Oncology Society of Brazil.

Michael Pearl, MD
Professor, Gynecologic Oncology
Stony Brook Medicine
United States

Specialty: Gynecologic Oncology and Palliative Care

Read Michael's Election Profile

IGCS Activities:

  • IGCS Education Committee Member, Palliative Care Work Group Co-Chair (2017-Present)
  • Project ECHO® Virtual Tumor Board Contributor (2018-Present)

Personal Statement:

While we have come far with our ability to care for our patients, we all too often still fail to meet our patients’ goals. As I’ve matured as a physician, I’m increasingly focused on improving the overall quality of life for women with gynecologic malignancies. Within my institution, I serve in a variety of leadership roles, allowing me the opportunity to develop programs addressing gaps in care and improving clinical and research services. Nationally, I serve on several committees focused on improving the provision of palliative care & hospice for women with gynecologic malignancies.

Annually, 1.3 million women develop a gynecologic malignancy worldwide, half of whom die; 56% of cases and 64% of deaths are in lesser developed countries.  Only 14% of adults who need palliative care receive it; 78% of those who need it are in lesser developed countries. Palliative care is a human rights issue; the World Health Assembly called upon the WHO and Member States to improve access to palliative care as a core component of health systems.

The purpose of IGCS includes “improvement in the quality of life” for women with gynecologic malignancies. Arguably, effective palliative care provides the greatest improvement in our patients’ quality of life, yet 70% of our members report no formal training in palliative care. There is a critical need to educate our members, as well local health care providers, in the principles of palliative care.

In 2018, I was given the privilege to serve as the co-editor of the IGCS Global Curriculum for Palliative Care. Working with a passionate and dedicated team, we developed a superb curriculum that will serve as a template to introduce practicing health care providers, primarily those in lesser developed countries, to the knowledge and skills necessary to provide effective palliative care and improve the quality of life for women with gynecologic malignancies.

International medicine, especially in lesser developed countries, has been a lifelong goal that I’ve deferred due to personal and professional constraints.  At this time in my life and career, I’m able to commit to international service. My work with IGCS members and leadership has been thoroughly enjoyable, rewarding and the highlight of my career.

Should I be elected to the IGCS Council, I will strive to assist the council and leadership in representing the IGCS membership and the women cared for by the members.  I believe that my experience as a senior gynecologic oncologist, palliative care specialist and seasoned administrative leader provides a unique perspective that will greatly benefit IGCS. In particular, I will work with IGCS to improve the provision of palliative care to those in need, especially in lesser developed countries.

My many years of clinical, research and leadership service, including serving on the equivalent of the IGCS Council, have given me substantial experience as a collaborative committee member and leader. It’s been a privilege and a pleasure to work with the members and leadership of IGCS; I welcome the opportunity to continue to do so as a Council member. 

Candidates for Council Member (Asia/Oceania)


Rhonda Farrell, BAppSc (Physio) DRANZCOG MBBS (Hons) FRANZCOG CGO MSurg  
Chris O’Brien Lifehouse, Royal Prince Alfred Hospital, University of Sydney

Specialty: Gynecologic Oncology

Read Rhonda's Election Profile

IGCS Activities

  • Presented at IGCS Biennial Meetings (Prauge 2010; Melbourne 2014)

Personal Statement:

I have been an IGCS Member since 2005. All women and their families deserve the highest standard of care for the prevention, detection and treatment of gynaecological cancer independent of where they live or their socio-economic situation.  Medical caregivers in wealthy countries have an obligation to assist those in poorer nations to provide this care through education and mentorship, new technologies, and financial support.

As a member of the IGCS Council, I would like to not only improve my own participation in these activities but to reach out and engage others to do the same. My best leadership qualities are my ability to engage the wider community to recognize these goals and support them through philanthropy, to mentor junior doctors and other colleagues to improve the quality of gynaecological surgery, and to foster and support research into gynaecological cancer.

I work well in a team as a driver of change and as a collaborator to support other members of the team to work to the best of their ability.  I have particular interest and experience in the following areas 1. fostering collaboration between surgical disciplines (gynaecological oncology and other oncological surgical specialties) to improve the standard of teaching of junior surgeons and to enhance the overall multidisciplinary care of women with abdominopelvic cancer, 2. supporting, mentoring and promoting collaboration between junior surgeons, oncology trainees and scientists in gynaecological cancer research, 3. working with young women in the community to engage them in careers in science, technology, engineering and medicine (STEM), and 4. engaging with consumers and the wider community to foster philanthropy and support improvements in cancer care. Through working with IGCS, I would like to expand these skills and apply them on an international platform to improve outcomes for all women with gynaecological cancer.

Dilyara Kaidarova, MD, PhD
Director, Kazakh Institute of Oncology and Radiology

Specialty: Gynecologic Oncology

Read Dilyara's Election Profile

IGCS Activities:

  • Kazakhstan Representative for the IGCS Strategic Alliance Partnership (2017-Present)
  • Project ECHO® Virtual Tumor Board Contributor (2018-Present)

Personal Statement:

Kazakhstan is the leading country among the CIS countries in the implementation of the National Cervical Cancer Screening Program and the HPV vaccination program. I have been the Director of the Kazakh Institute of Oncology and Radiology for the past four years. The main objective is to improve the quality of cancer care in Kazakhstan. Numbers of programs have been initiated to improve the quality of Cancer Care under Kazakh Institute of Oncology and Radiology leadership. The ImPACT Mission Review of Cervical Cancer Screening Program was initiated in Kazakhstan. In the result of these we improved cervical cancer screening coverage of the target population.

Why am I running for Council Member practicing in Asia?

The main purpose of my work as an IGCS Council Member will be to attract gyn-oncologists from Kazakhstan’s neighboring countries to the IGCS. Kazakhstan has just begun to take steps to cooperate and collaborate with international medical societies. These partnerships opened the opportunity for Kazakhstan to develop evidence-based medicine in the cancer care area, learn from the experience of foreign colleagues, and participate in international research and projects. I hope that Kazakhstan will become a bridge in the cooperation of the countries of Central Asia with the leading specialists of IGCS.

Joining the post of council will strengthen the work on the prevention of cervical cancer not only in Kazakhstan, but also in Central Asia. The work will be carried out to attract international studies as well as training specialists from neighboring countries.

Asima Mukhopadhyay, MD, PhD, MRCOG, MSc
Consultant Gynecological Oncologist
Chittaranjan National Cancer Institute Kolkata, India
Northern Gynecological Oncology Centre, Gateshead, United Kingdom

Specialty: Gynecologic Oncology

Read Asima's Election Profile

IGCS Activities:

  • IGCS Education Committee Member, General Gynecologic Oncology Workgroup (2018-Present)
  • International Mentor, IGCS Gynecologic Oncology Global Curriculum & Mentorship Program for Civil Service Hospital, Nepal (2018-Present)

Personal Statement:

My professional career has prioritised:

  1. Promoting education and training in low-middle income countries (LMICs-India/Nepal) including development of cytoreductive and minimal access surgery programs. I currently supervise two Nepalese trainees in the Global Curriculum Programme.
  2. Translational/clinical research with focus on developing low-cost biomarkers and interventional trials suited for the need for women residing in LMICs. I have been able to successfully develop and lead a co-operative research group – Kolkata Gynecological Oncology Trials and Translational Research Group (KolGoTrg) which is the first ever group from India to be represented in GCIG. We have 3 CCRN sites and hope to build up a network in ovarian cancer (OCRN) keeping in mind the increasing trend globally. The royalty that I receive, being one of the co-inventors of the PARP inhibitor rucaparib has been donated to support this work.

While working in India and the UK and mentoring the IGCS global curriculum in Nepal, my reflection is that many gynecological oncology regional centers in Asia/Oceania currently may not have access to a structured program as robust and inclusive as the IGCS module even if there are local board-certified programs.  

As an IGCS Council Representative from Asia-Oceania, my role will be:

  1. Expanding the IGCS curriculum especially in LMICs/sites which cannot obtain local accreditation due particularly to the number of positions although otherwise fulfilling the IGCS criteria. All regional cancer centers may be eligible to become IGCS certified as well if they opt for and fulfill the standards/criteria. With an increase in the number of sites, it may not be possible for one person/central IGCS organization to co-ordinate this effort and we may have to have region specific leaders who will develop tumor boards/training sessions/international mentoring in a more time-zone/cost-efficient manner. One example being the India-Nepal partnership. However, there is need for developing “training the trainers” modules and short courses/travelling fellowships for the trainers as a pre-requisite to this expansion so that the quality and parity is ensured between regions.
  2. I would promote development of an IGCS certified nursing training program and courses/mentorship schemes for health care assistants/social workers working in the field of gynecological cancers.
  3. I will develop a minimal dataset (through a data harmonization committee and determination of standards/ audit trail for data quality) for data capture for women presenting with symptoms/referral patterns and treatment/defaults/outcomes/ survival trends. This could be based on databases like REDCap. Centers participating in this scheme and maintaining a track record for prospective and periodic data capture for at least 2 years will be certified as IGCS data centers and have incentives towards participation at IGCS meetings. Members in each region can be identified to lead on this responsibility. This will improve membership/retention/local empowerment.
  4. I will promote publications of grey literature/structured reports/audits from regional centers through the IGCS education portal (divided in region specific sections and templates) and journals like Gyn Oncology Reports. Fellows/young scientists and clinicians will be encouraged to promote clinician-scientist interactive forums.

It is an honour to be considered for this position.

Candidates for Council Member (Europe)

Donal Brennan, PhD
Professor of Gynaecologic Oncology
University College Dublin

Specialty: Gynecologic Oncology

Read Donal's Election Profile

IGCS Activities:

  • IGCS Annual Global Meeting Scientific Program Committee, European Regional Co-Chair (Rio de Janeiro 2019)
  • IGCS Education Committee Member, General Gynecologic Oncology Workgroup (2019-Present)
  • International Mentor, IGCS Gynecologic Oncology Global Curriculum & Mentorship Program for University of West Indies, Jamaica (2018-Present)
  • Course Director, Shingo Fujii Young Doctors Summit (Melbourne 2014; Lisbon 2016; Kyoto 2018)

Personal Statement:

The IGCS is a truly global society and its activity in both the developing and developed world are what makes serving as a Council Member so attractive. The opportunity to have a global impact on policy, training, and ultimately improve outcomes for all women affected by gynaecological cancer irrespective of their geographical location are the main reasons I would like to serve on the IGCS Council. My own experience in addressing serious concerns around HPV vaccination and cervical screening in Ireland have allowed me to develop a collaborative leadership approach with politicians, patients, and the public.

If elected, I would focus on developing even closer links to patient advocates.  Many problems in medicine arise from poor communication.  I firmly believe that as medical technology advances, communication with patients and their families will become more challenging. I believe the only approach to address this issue is to incorporate patient experience and shared vocabularies into clinical and research practices.  Technologies such as next generation sequencing and personalised medicine are developing at an astonishing rate, however cultural narratives around illness and medicine do not have the same agility; for example, while we may intervene at a genetic level to treat a cancer using a PARP inhibitor, we do not have a word for parents who have lost a child. As a consequence, there is a communication gap between the capacity of medicine and its delivery. Patients and doctors are literally not speaking the same language.  

Therefore, if elected, I would work on developing meaningful and lasting partnerships with international patient advocates form a variety of geographical regions. The goal of this partnership would be to develop an international shared vocabulary for women with gynaecological malignancy. As a truly international society, the IGCS is uniquely positioned to develop this kind of resource which would have a major impact on the daily practice of its members but would also provide a lasting resource for women all over the world with gynaecological cancer. 

Daniela Luvero, MD
University Campus Bio Medico of Rome

Specialty: Gynecologic Oncology

Read Daniela's Election Profile

IGCS Activities:

  • Active participant in IGCS Meetings since 2010
  • Collaborated with the IGCS to plan workshops, conferences, and presentations for the IGCS Biennial Meetings (Lisbon 2016; Kyoto 2018) and the Annual Global Meeting (Rio de Janeiro 2019: Rome 2020)

Personal Statement:

My name is Daniela Luvero and I have always been interested in Gynecologic Oncology. It was a great privilege and honor to have been recently nominated for the position of Council Member for Europe.

I have been devoted to Gynecologic Oncology for my whole life. In 2013, I was a clinical fellow in the Gynecologic Oncology Unit at University College Hospital in London under the supervision of JA Ledermann, participating in research protocols and clinical activities. I am currently in the PhD Oncology course, following research on the early diagnosis of ovarian cancer.

Since 2010, I have been an active participant in IGCS meetings, and from 2015 onwards I have collaborated in IGCS planning workshops, conferences and presentations. I have participated in round tables, have served on the industry advisory board and have spoken at national and international conferences. I am a contributing author to several national and international papers regarding the prevention, treatment, and study of gynecologic cancer, with a specific attention to quality-of-life.

Most of my work has been dedicated to advocacy programs, collaborating with several national and international patients’ associations. I endeavor to ensure that all people impacted by cancer are empowered through knowledge, strengthened by action, and sustained by community, through online, in-person, and phone-based counseling and support groups and through educational workshops and publications.

As an IGCS Council member, I would like to offer my experience in survivor-patient advocacy programs and contribute to women’s empowerment globally, especially in low-income countries, to improve women’s understanding of cancer prevention, risks, screening tests and treatments. I would also leverage my youth to meaningfully engage young doctors in the work of the IGCS.

If I were selected it would be my honor to contribute to improving advocacy- and community-centered programs and to engage survivors-patients, caregivers, families, and advocates globally.

Lukas Rob, MD, PhD
Department of Obstetrics and Gynecology, 3rd Medical Faculty, Charles University Prague, Oncogynecology Center University Hospital Kralovske Vinohrady
Czech Republic

Specialty: Gynecologic Oncology

Read Lukas' Election Profile

IGCS Activities:

  • IGCS Finance Committee Member (2006-2010)
  • IGCS Biennial Meeting Scientific Program Committee, President of Local Organizing Committee (Prague 2010)
  • IGCS Nominating Committee Member (2015-2016)

Personal Statement:

With the nomination and possible election to the IGCS Council as the representative of oncogynecologists for the European region, I would like to contribute with my work experience to the further development of the society and to help achieve well-set strategic goals.

From my point of view, the most important effort is to achieve optimal care in women with gynecologic malignancies in individual regions of the world, to help build infrastructure of oncogynecological care according to real local possibilities.

In particular I see possibilities in improving education, training programs, and sharing experience with building infrastructure of oncogynecological care. These programs must be organized in cooperation with local societies and leading physicians. I will be honored to contribute with my work in the further development of IGCS.

Candidates for Council Member (Radiation Oncology)

Thomas Samuel Ram, MD
Professor & Associate Director (Missions)
Ida B Scudder Cancer Center, Christian Medical College Vellore

Specialty: Radiation Oncology

Read Thomas' Election Profile

IGCS Activities:

  • IGCS Education Committee Member, Radiation Oncology Work Group (2019-Present)
  • IGCS Travelling Scholar Recipient (2008)

Personal Statement:

I have been an Active Member of IGCS since 2006, and I feel privileged to have received generous support and guidance from IGCS for my early career development which enabled invaluable global exposure to oncology. I had the honour of being awarded the IGCS travelling scholar award in 2008 which supported my training for Cervix brachytherapy at Long Beach Memorial Hospital, California.

Over the past several years I have been involved in various national and international activities, recently involving WHO, IGCS, and International Cancer Expert Corps (ICEC) which has added a global perspective professionally and personally. I feel this opportunity will enable me to contribute globally with the experience and skill I have gathered through my international engagement. Serving on the IGCS Council will provide an opportunity to utilise my talents in health care leadership, global networking and my experience serving in a not-for-profit academic institution and in underserved areas.

If I am elected, I would like to demonstrate effective stewardship of this role and responsibility. I would like to develop a strategy to further the impact mandate of IGCS – Educate, Collaborate, Unite, Mentor. I would like to address issues that will bridge the global health gaps, especially in gynaecological oncology by developing appropriate strategies for resource-stratified education and training – thus enabling high quality, affordable cancer care.

I would also like to develop health care models as the future of health care is transitioning to a shifting paradigm of care shift and role shift. This paradigm will perhaps be the solution for filling the gaps in the oncology care value chain where work force shortage of oncology professionals is already leading to significant health care disparities. I believe this will be one of the key strategies if we need to strengthen the interdependence within various health care professionals in our health care value chain, especially as we seek to implement the Global Strategy for Elimination of Cervical Cancer as envisioned by the WHO.

I have been fortunate to be mentored into health care leadership as early as my medical school days in the early 1990s. I had the privilege of leadership experience especially in underserved areas and in not-for-profit academic organisations which has placed me at a unique position of thinking from a perspective of lean health care in oncology. The vision of our institution CMC Vellore of compassionate clinical care, educational, and research excellence in sustainable systems has enabled me to experience a passionate commitment to the most vulnerable people while at the same time promoting cutting-edge education, service, and research.

Due to my visits to international cancer centres and interaction with several global oncology leaders, my networking strengths will be appropriately useful through this responsibility. My ongoing training in MBA (Health Care Systems and Hospital Management) will also add value to the role as an international representative of the Radiation Oncology community in IGCS. I believe that this responsibility will provide an opportunity on a global platform for a fulfilling experience as an oncologist as it will enable meaningful global partnerships towards effective cancer care.

Alexandra Taylor, MD
Royal Marsden Hospital, London
United Kingdom

Specialty: Radiation Oncology

Read Alexandra's Election Profile

IGCS Activities:

  • IGCS Annual Global Meeting Scientific Program Committee Member (Rio de Janeiro 2019)
  • Project ECHO® Virtual Tumor Board Contributor (2019-Present)

Personal Statement:

I would like to serve as a member of the IGCS council because this would be a great opportunity to become more involved in developing excellence in care for women with gynecological cancer. The IGCS multi-disciplinary approach is essential for optimising outcomes and supporting education, research and healthcare with a global focus. I bring enthusiasm, commitment and a strong collaborative approach, with experience of working within national and international committees. My areas of particular interest are radiotherapy development, training and patient survivorship.

I believe the international collaboration that exists within IGCS provides opportunities to further develop education and training in radiation oncology. My research background has included development of internationally adopted guidance on radiotherapy target volumes. I have developed and led IMRT workshops and national radiation oncology meetings on gynaecological cancer. The rapid pace of recent developments in radiation oncology offers exciting opportunities to improve outcomes for patients. But to support these advances we require robust validation and quality assurance, particularly as new techniques including stereotactic radiotherapy, re-irradiation and combination therapies with immunotherapy are increasingly being used.

Radiotherapy is an essential primary treatment for cervical cancer globally and there remains a huge need to improve the available resources in many countries. IGCS has already developed a successful international mentorship program for gynecology oncology surgery and I would aim to promote a similar program for training and mentorship in radiation oncology.

In addition, with the significant improvements we are making in cancer treatment, we now have increasing numbers of long-term survivors. Treatment effects can have a significant impact on the quality of life for patients. Survivorship programmes and management of the consequences of treatment is an important field of patient care that I am keen to highlight within IGCS.

COVID-19 & Gyn Oncology Virtual Tumor Boards

Information regarding the understanding of COVID-19 is continually evolving and its impact on the care of gynecologic oncology patients is rapidly changing. Bringing together the global gynecologic oncology community under such unprecedented circumstances will allow IGCS to learn the needs of our members and further expand our education offerings. IGCS has had great success using the Project ECHO tele-mentoring model to host virtual tumor boards over the last three years.

We are now expanding our Project ECHO Virtual Tumor Boards, extending an invitation to our members to come together to discuss gynecologic oncology cases with special considerations for COVID-19. We will host a series of three virtual tumor boards in the coming weeks.

The Project ECHO Model:
An international faculty will present a problem-based case presentation followed by a 10-minute didactic lecture specific to COVID-19. The presentations will be followed by 20 minutes question and answer segment. Participants may submit questions or submit topics of discussion at the time of registration or ask questions during the session.

Saturday, April 4 (8:00 A.M. America/Chicago, 1:00 P.M. UTC)            REGISTER
View the time zone converter for this event.

Tumor Board Topic: How COVID-19 is affecting the management of women with suspected gynecologic malignancies. Reviewing delays in diagnostic and therapeutic interventions.
Moderator: Ritu Salani (USA)
Case presenter: Wendel Naumann (USA)
Didactic Presenter: Emma Rossi (USA)  How long is it safe to delay gynecologic cancer surgery?
Panelists: Daniela Luvero (Italy), Rene Pareja (Colombia), and June Liu (China)

Tuesday, April 14 (8:00 A.M. America/Chicago, 1:00 P.M. UTC)           
View the time zone converter for this event.
More information on this tumor board and a link to register will be posted here as it becomes available.

Tuesday, April 28 (8:00 A.M. America/Chicago, 1:00 P.M. UTC)           
View the time zone converter for this event.

More information on this tumor board and a link to register will be posted here as it becomes available.

Submit Questions and Topics for Discussion:
During registration, we ask that you provide us with any questions you may have in advance and we will make every effort to answer the questions during the tumor board. When you register, a link will be sent to you with instructions on how to access the tumor board live. A video recording of the tumor board will be available after the session.

We are currently preparing cases and securing faculty for each tumor board. Information regarding the cases and didactic lectures to be discussed, the names of moderators, panelists, and presenters will be available here in advance of each session.

We look forward to connecting with you.

Ritu Salani, MD
IGCS Education Committee Chair

Ane Gerda Eriksson, MD, PhD
IGCS Education Committee Vice Chair

COVID-19 Resources & a Message from our President

COVID-19 Resources

COVID-19 & Cancer 

In the News

Connect with Others: IGCS Member Community

Visit the IGCS Social Link Discussion Forum created for Members to discuss issues and share resources related to COVID-19.

IGCS President, Prof. Roberto Angioli speaks about COVID-19 from his office in Rome.

Transcripts of Prof. Angioli’s message are available in the following languages: English, Italian, Arabic, Chinese, Japanese, Portuguese, and Spanish.

Nominations for Distinguished Advocacy Award

The Award

The Annual IGCS Distinguished Advocacy Award recognizes advocates and/or advocacy organizations that provide active, dedicated service to patients-survivors, families, caregivers, and communities—at a local, regional, or international level. The Award, reserved for those most persistently engaged in the fight against gynecologic and other cancers,

  • recognizes those currently engaged in activities and projects that tangibly provide benefit to patient-survivor communities
  • highlights best practices and outstanding individuals and organizations in various settings throughout the world
  • inspires others to engage so generously

Annually, IGCS honors up to three individuals and organizations from different regions of the world, and special consideration is given to those who collaborate beyond their community or country of residence. Award recipients will

  • attend the 2020 IGCS Annual Global Meeting in Rome (September 10-12), with support from IGCS
  • be recognized at the Global Meeting during a Plenary session and during the Survivor-Caregiver Symposium
  • receive a plaque in recognition of the Award
  • be highlighted on the Advocacy pages of the IGCS website

Accepting Nominations for 2020

IGCS is currently accepting nominations for its 2020 Distinguished Advocacy Award. The deadline for receipt of nominations for the 2020 Award is April 15, 2020, at 11:59 pm EST. Award recipients will be determined by a Selection Committee with IGCS Council consultation. In selecting award recipients, we will consider global distribution of the award and regional ableness; however, these will not be the primary considerations. We accept self-nominations.

Award recipients must be patients-survivors, family members, caregivers, or other individuals who make outstanding contribution(s) to the patient-survivor community and be engaged in one or more of the following areas:

  • advocating for enhanced cancer awareness and prevention
  • providing or advocating for the delivery of the highest-quality cancer care
  • supporting achievement of the highest quality of life possible (to include support or palliative care)
  • implementing program(s) that support and/or advance health equity
  • collaborating with other advocates and/or advocacy organizations to benefit patients-survivors across geographic boundaries and demographics

Nominees do not have to belong to an established organization but must be active in their own community and/or beyond. In each calendar year, only one person or organization from a region can receive the Award.

Click here to Download the Nomination Form.
Click here to Submit the Completed Nomination Form.

If you have questions or need assistance, please email the IGCS Director of Global Outreach and Engagement, Mary (Dicey) Jackson Scroggins at dicey.scroggins@igcsdev.com.

Education Highlight: IGCS-IJGC Interactive Learning Articles

Education Highlight: Interactive Learning Articles

A New Offering from the IGCS Education Committee: IGCS-IJGC Interactive Learning Articles

We are excited to announce that the IGCS Education Committee’s Work Group on Gynecologic Cancer has developed a new interactive learning feature that allows members to test their knowledge while reading select articles published in the International Journal of Gynecological Cancer.

Work group leader, Dr. Paul Cohen (Australia) developed a series of multiple choice and true/false questions related to key concepts within the first selected article.

Visit the IGCS Member Education Portal to download the first IGCS-IJGC Interactive Learning Article:

Lower extremity lymphedema in patients with gynecologic malignancies
January 7, 2020
Authors: Kimberly Dessources, Emeline Aviki, Mario M Leitao Jr

Dr. Cohen says he is “excited to assist the IGCS Education Committee in developing new and relevant ways to use content especially from our journal – The International Journal of Gynecological Cancer. We hope that these interactive learning articles will improve retention of knowledge and enhance readers’ educational experience. I am very grateful to Dr. Pedro Ramirez, Editor in Chief of the International Journal of Gynecological Cancer, for assisting with selection of appropriate articles.”

When reading the Interactive Learning Article, test your comprehension by answering a series of questions.

The correct answer is highlighted on the following slide.

This resource has been developed by members of the IGCS Education Committee General Gynecologic Oncology Work Group and they will be creating more interactive learning articles throughout the year.

We hope that these interactive articles will increase learner engagement and make learning fun.

We would like to thank Dr. Pedro Ramirez, Editor-in-Chief of the International Journal of Gynecological Cancer, BMJ Publishing, and all the authors of the selected papers, for their generosity in making these articles available to IGCS members.

We hope you enjoy them and have fun learning!


Now Accepting Abstracts for IGCS 2020

Submit your Abstracts for IGCS 2020

Submission Deadline: May 1, 2020

IGCS is seeking all medical professionals who are a part of the gynecologic and breast cancer care team to submit abstracts for the 2020 Annual Global Meeting of the International Gynecologic Cancer Society which will be held in Rome, Italy from September 10 – 12, 2020.

We are currently accepting abstracts to be considered for oral or poster presentation. All abstracts must be original work, and not previously published or orally presented at other scientific meetings. Select posters will be chosen as oral presentations for the featured poster session: “Walk the Posters with a Professor” in the exhibit hall.

Surgical film submissions will be accepted from April 1 – May 15.

Abstract Topics:

Basic/Translational Science
Genetics And Epidemiology
Gynecologic Pathology/Cytology & Disease Pathogenesis
Cervical Cancer
Uterine Cancer Including Sarcoma
Ovarian Cancer
Rare Tumors & Gestational Trophoblastic Neoplasia
Vulvar & Vaginal Cancer

Early Phase Clinical Trials
Trials In Progress
Symptom Management/Supportive Cancer Care
Nursing & Health Care
Global Health
Surgical Techniques & Perioperative Management
Surgical Films
Pre-Invasive Disease
Palliative Care

Click Here To Submit

If you have questions or need assistance, please email igcs2020@mci-group.com.

Education Highlight: Select Webcasts

Education Highlight: IGCS 2019 Annual Global Meeting Webcasts

Did you miss IGCS 2019 in Rio? Were you there and could not attend all the talks you wanted to? Like every meeting there was an abundance of excellent presentations including new research, clinical trials and review sessions.

This month we highlight two sessions from Rio which we hope you will find interesting and relevant to your practice. Members can view these two webcasts in the Member Education Portal.

Translating Endometrial Molecular Risk Stratification To Endometrioid Ovarian Carcinoma: A Novel Application Of Precision Medicine
7 minute presentation
Dr. Pauline Kramer and colleagues applied the validated Proactive Molecular risk Classifier for Endometrial cancer (ProMisE) to an international cohort of over 500 well characterized endometrioid ovarian carcinomas. All four molecular subtypes were identified (POLEmut, mismatch repair deficient (MMRd), p53wt/NSMP and p53abnormal(p53abn)), and molecular subtype was associated with clinical outcomes (PFS, DSS) including no recurrence events within POLEmut at 10 years and very poor outcomes within p53abn (only ~ 50% survival at 10 years). Association of outcomes with ProMisE was maintained on multivariable analysis. Possible utility of this molecular framework to endometriosis-associated ovarian carcinomas is discussed.

Concerv: A Prospective Trial Of Conservative Surgery For Low-Risk Early Stage Cervical Cancer
15 minute presentation
Dr. Kathleen Schmeler shares the results of an international collaborative prospective single arm study assessing the safety and feasibility of simple (non-radical) hysterectomy or cone biopsy with lymph node (LN) assessment for early stage cervical carcinoma and with favorable pathology characteristics. Final analysis includes 100 patients with a 4.3% recurrence rate observed thus far. Lymph node (LN) involvement was diagnosed in 5% of women confirming the importance of LN assessment. Further follow-up is needed to determine if long-term oncologic outcomes are comparable to women who had undergone radical procedures and two additional prospective studies (SHAPE, GOG 278) in early cervical carcinoma are pending which will also help clarify if less aggressive surgical approach is safe.

See more: View over 150 presentations from the 2019 Annual Global Meeting.






IGCS & WOCC Join Forces


Announcing a Strategic Advocacy Partnership Between the International Gynecologic Cancer Society and the World Ovarian Cancer Coalition

It is my pleasure to announce a Strategic Advocacy Partnership between the International Gynecologic Cancer Society (IGCS) and the World Ovarian Cancer Coalition (WOCC). This partnership maximizes the collective influence, membership, force, and reach of these two premiere organizations and establishes a framework through which they will provide tangible benefit to gynecologic cancer survivors-patients worldwide, with special emphasis on ovarian cancer.

Established in 2016, WOCC is a not-for-profit organization with 145 patient advocacy organization partners in 37 countries. WOCC works to ensure that every woman diagnosed with ovarian cancer has the best chance of survival and the best quality of life possible, wherever she may live. Its mission aligns perfectly with that of the IGCS of enhancing the care of women with gynecologic cancer worldwide. Uniting the globe in the fight against gynecologic cancers since 1985, IGCS currently has over 3,200 members in 115 countries. The membership of both organizations encompasses low-, middle-, and high-resource countries, consistent with their commitment to global health equity.

Elisabeth Baugh, Chair of the World Ovarian Cancer Coalition, explains, “As the largest global ovarian cancer patient advocacy network, the World Ovarian Cancer Coalition is committed to making a difference to the lives of all women affected by ovarian cancer. This strategic partnership creates a powerful global advocacy movement, uniting and strengthening patient and clinical voices to act as a force for urgent change. It is our firm belief that we will achieve much more together.”

With each organization retaining its independence, focus, and governance and with each committed to mobilizing outstanding global leadership, experts, and advocacy to reduce the burden of gynecologic cancers globally, this partnership does indeed represent a formidable force for change.

Emphasizing the importance of advocacy partnerships, IGCS President Roberto Angioli notes, “This partnership with the World Ovarian Cancer Coalition is representative of our commitment to working collaboratively with advocates worldwide to ensure best outcomes for all women and families affected by gynecologic cancers. We will continue to partner with local, regional, and global advocacy groups across all gynecologic cancer sites. These partnerships are essential to our mission.”

And, specifically, in activating this partnership, we will

  • Launch the WOCC’s Global Ovarian Cancer Charter—a call-to-action to all involved in the care of ovarian cancer survivors-patients—during the 2020 IGCS Annual Global Meeting in Rome.
  • Convene cancer site-specific partnership meetings and other forums that support the IGCS-initiated Global Advocacy Network focused on gynecologic cancers.
  • Integrate into IGCS, WOCC, and other international meetings, our individual organization-specific, mission-driven programming that supports advocacy broadly.

Together, IGCS and WOCC will amplify the global voices of gynecologic cancer survivors-patients and will prompt and accelerate change that expands awareness and options, improving survival rates and survivorship. To manage joint initiatives, each organization has a dedicated partnership lead—Dicey Jackson Scroggins, IGCS Director of Global Outreach & Engagement, and Clara MacKay, WOCC Executive Director.

We are well positioned to take on the challenges and excited by the opportunities to benefit women and families—wherever and under whatever circumstance they might live.


Mary Eiken, MS
IGCS Chief-Executive Officer

IGCS Year-End Overview

This past year, the International Gynecologic Cancer Society has achieved great things thanks to the support and contributions of our members.

In 2020, we hope to accomplish even more together.

Thank you for being a part of our global community, united through our dedication to enhance the care of women with gynecologic cancer worldwide through education and training and public awareness.

Wishing you all the best in the new year!

2020 Council Nominations & Elections

Dear IGCS Member,

We are currently seeking committed volunteers to apply for leadership positions to help guide the society’s strategic direction and work towards our mission of uniting the globe in the fight against gynecologic cancers.

Why we need Leaders to Volunteer for Council Service

Perhaps the most important and influential part of what we do as a society is ensuring that our leadership is comprised of experienced and dedicated members to carry out our mission of improving outcomes for women affected by gynecologic cancer through teaching, mentorship and training.

Our council and committees now reflect the gender and diversity of our membership and we have become a truly international society reaching out to all corners of the globe. It is even now more important that future councils are truly representative of our global membership. To this end, the IGCS region previously assigned to Europe, Africa and the Middle East has now been divided into separate regions to ensure better representation.

Open Council Positions in 2020

  • President Elect (from Asia or Oceania, based on rotation)
  • Vice President (global region unspecified)
  • Secretary-Treasurer Elect (global region unspecified)
  • Four Council Members
    • Gynecologic Oncologist practicing in the Americas (North, Central, or South) or the Caribbean
    • Gynecologic Oncologist practicing in Europe
    • Gynecologic Oncologist practicing in Asia or Oceania
    • Radiation Oncologist (global region unspecified)

View the current Council roster here.


If you are interested in serving on the Council, please submit a completed application form with your digital photograph and recent CV. If you know someone whom you feel should serve, please encourage them to apply.

The deadline to apply is Sunday, February 16, 2020.

All active Members are eligible to apply for council service, including Strategic Alliance Partners, except for Senior Members. If you are considering applying, please check that your IGCS Membership is current and that you have renewed for 2020.

Review complete information about the open positions and the nominations and election process here.

Nominating Committee: Slate Selection

IGCS uses a transparent and balanced approach to reviewing and scoring the applications. Our bylaws specify that the Nominating Committee consists of the Past President (chair), current President, President-Elect and two IGCS members at large (appointed by the chair and approved by council).

2020 Nominating Committee:

  • Michael Quinn (Australia)
  • Roberto Angioli (Italy)
  • Robert Coleman (USA)
  • June Liu (China)
  • Amita Maheshwari (India)

Each applicant will be scored individually by each committee member without discussion, using pre-determined criteria. The committee will then meet to discuss the scores and determine the best slate of candidates to be presented to the council for approval and finally to the membership for vote. No more than three (3) candidates shall be slated for each open position.

Open Elections & Regional Voting Segments

The election will be managed by an independent company that specializes in conducting secure elections for groups such as ours. Members with voting rights will be emailed an electronic ballot with information about each candidate at the beginning of April. Online voting will remain open for 30 days and announcement of those elected by majority vote will occur mid-May.

New Policy: Starting with this election, IGCS is implementing segmented voting for regional Council member positions to allow regions to elect their representatives. Regional Council members will be elected by majority vote of IGCS members residing in the specified region. For example, only members residing in European countries are eligible to vote for the European Council member representative.

All members with voting rights may cast votes for candidates running for Officer positions (President Elect, Vice President, Secretary-Treasurer Elect) and Council member positions of unspecified global region.

If you have any questions or comments about the process please contact our CEO, Mary Eiken at mary.eiken@igcsdev.com.


Prof. Michael Quinn
IGCS Nominating Committee Chair & Immediate Past President